Sun 29 Nov 2009 | 5:44 EST
You are here: Home > Business & Finance > Stocks > Officers and Directors
Home
Business & Finance
Markets
Deals
Small Business
Green Business
Industries
Industry Summits
Stocks
Advanced Stock Search
Overview
Option Quote
Chart
Officers and Directors
Key Developments
Company News
Press Releases
Financial Highlights
Ratios
Financial Statements
Performance
Insider Trading
Institutional Holders
Estimates
Recommendations
Analyst Research
Funds
ETFs
Currencies
Commodities
Options
Economy
Bonds
Analyst Research
Portfolio
News
Do More With Reuters
RSSRSS Feed
Widgets
Mobile
Podcasts
Newsletters
Your View
Partner Services
CareerBuilder
Affiliate Network
Professional Products
Support (Customer Zone)
Reuters Media
Financial Products
About Thomson Reuters

Officers and Directors For BioMimetic Therapeutics, Inc.

BioMimetic Therapeutics, Inc. (BMTI.O) (Consolidated Issue listed on NASDAQ Global Market)
sector: Healthcare . industry: Biotechnology ยท View BMTI on other exchanges
As of  27 Nov 2009
10.88USD
Price Change
-0.37
Percent Change
-3.29%
 
Research Another Stock: Symbol Look-up

Name Age Since Current Position
Pagano, Russell 43 2007 Vice President - Regulatory and Clinical affairs
Lynch, Samuel 49 2005 President, Chief Executive Officer, Director
Douglas, Earl 46 2005 General Counsel
Ehrlich, Christopher 39 2004 Director
Murphy, James 53 2005 Director
Watson, Douglas 64 1999 Director
Friedlaender, Gary 63 2006 Director
Federico, Charles 60 2007 Director
Christensen, Thorkil -- 2009 Director
Hirsch, Steven 57 2005 Chief Operating Officer, Executive Vice President - Orthopedics
Bullock, Lawrence 53 2004 Chief Financial Officer
Papasan, Larry 68 2005 Chairman of the Board